AI assistant
Varex Imaging Corp — Director's Dealing 2017
Feb 10, 2017
32856_dirs_2017-02-09_eda1cc59-f342-4710-b7ba-28c8e4e2c501.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Varex Imaging Corp (VREX)
CIK: 0001681622
Period of Report: 2017-01-28
Reporting Person: VERHOEF CLARENCE R (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-01-28 | Non-Qualified Stock Option (right to buy) | $22.84 | A | 21047 | Acquired | 2019-11-09 | Common Stock (21047) | Direct |
| 2017-01-28 | Non-Qualified Stock Option (right to buy) | $27.77 | A | 22063 | Acquired | 2021-02-21 | Common Stock (22063) | Direct |
| 2017-01-28 | Non-Qualified Stock Option (right to buy) | $30.74 | A | 27116 | Acquired | 2022-02-13 | Common Stock (27116) | Direct |
| 2017-01-28 | Non-Qualified Stock Option (right to buy) | $25.17 | A | 47786 | Acquired | 2023-02-12 | Common Stock (47786) | Direct |
| 2017-01-28 | Restricted Stock Units | $ | A | 1601 | Acquired | 2018-02-15 | Common Stock (1601) | Direct |
| 2017-01-28 | Restricted Stock Units | $ | A | 3618 | Acquired | 2019-02-15 | Common Stock (3618) | Direct |
| 2017-01-28 | Restricted Stock Units | $ | A | 8611 | Acquired | 2020-02-15 | Common Stock (8611) | Direct |
Footnotes
F1: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant.
F2: Option fully vested three years from grant date.
F3: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 21, 2014 and the remaining vests monthly thereafter.
F4: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 13, 2015 and the remaining vests monthly thereafter.
F5: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 12, 2016 and the remaining vests monthly thereafter.
F6: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock.
F7: These RSUs vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.
F8: These RSUs vest in two equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.
F9: These RSUs vest in three equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date.